Novartis targets 5%+ annual sales growth through 2029 amid robust brand performance
CEO Vas Narasimhan highlighted Novartis' strong performance in Q4 2024, with sales increasing 16% and core operating income rising 29% in constant currency. For the full year, the company achieved a ...